Sairah R. Khan

Fulham Palace Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised, non-comparative, open label, phase II study: RHEPaiR.

Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised, non-comparative, open label, phase II study: RHEPaiR.

Journal: BMJ open
Published: November 20, 2025

Evaluation of the impact of novel digital PET/computed tomography reconstructions in Herder score calculations for the assessment of solitary pulmonary nodules on 2-[ 18 F]fluoro-2-deoxy-D-glucose PET/computed tomography.

Evaluation of the impact of novel digital PET/computed tomography reconstructions in Herder score calculations for the assessment of solitary pulmonary nodules on 2-[ 18 F]fluoro-2-deoxy-D-glucose PET/computed tomography.

Journal: Nuclear medicine communications
Published: October 29, 2025

Erratum for: Dual-Energy X-ray Absorptiometry in Osteoporosis and Osteopenia: Imaging Interpretation and Pitfalls.

Erratum for: Dual-Energy X-ray Absorptiometry in Osteoporosis and Osteopenia: Imaging Interpretation and Pitfalls.

Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: June 04, 2025

Dual-Energy X-ray Absorptiometry in Osteoporosis and Osteopenia: Imaging Interpretation and Pitfalls.

Dual-Energy X-ray Absorptiometry in Osteoporosis and Osteopenia: Imaging Interpretation and Pitfalls.

Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: May 08, 2025

Low risk of thyroid eye disease (TED) following radioiodine (RAI) therapy in a multidisciplinary setting: a retrospective cohort study.

Low risk of thyroid eye disease (TED) following radioiodine (RAI) therapy in a multidisciplinary setting: a retrospective cohort study.

Journal: Thyroid research
Published: April 05, 2025

Study protocol of LANTana: a phase Ib study to investigate epigenetic modification of somatostatin receptor-2 with ASTX727 to improve therapeutic outcome with [177Lu]Lu-DOTA-TATE in patients with metastatic neuroendocrine tumours, UK.

Study protocol of LANTana: a phase Ib study to investigate epigenetic modification of somatostatin receptor-2 with ASTX727 to improve therapeutic outcome with [177Lu]Lu-DOTA-TATE in patients with metastatic neuroendocrine tumours, UK.

Journal: BMJ open
Published: October 25, 2023

Somatostatin Receptor Imaging with [18F]FET-βAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study.

Somatostatin Receptor Imaging with [18F]FET-βAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 22, 2023

Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands.

Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands.

Journal: The British journal of radiology
Published: September 12, 2023

Contemporary Multimodality Imaging of Primary Hyperparathyroidism.

Contemporary Multimodality Imaging of Primary Hyperparathyroidism.

Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: April 15, 2022

Treatment of Neuroendocrine Neoplasms with Radiolabeled Peptides-Where Are We Now.

Treatment of Neuroendocrine Neoplasms with Radiolabeled Peptides-Where Are We Now.

Journal: Cancers
Published: December 20, 2021

A rare cause of severe Cushing's syndrome.

A rare cause of severe Cushing's syndrome.

Journal: Endocrinology, diabetes & metabolism case reports
Published: February 21, 2020

Quantitative evaluation of beta-amyloid brain PET imaging in dementia: a comparison between two commercial software packages and the clinical report.

Quantitative evaluation of beta-amyloid brain PET imaging in dementia: a comparison between two commercial software packages and the clinical report.

Journal: The British journal of radiology
Published: April 25, 2019
Showing 1-12 of 21

Last Updated: 09/26/2026